Abbvie, US reach agreement to cut drug prices

 

Jan 12 (Reuters) – Abbvie reached a three-year agreement with U.S. President Donald Trump’s administration to provide low prices in Medicaid through TrumpRx, and pledged $100 billion over the next decade for research and development in the U.S., the company said on Monday.

(Reporting by Ruchika Khanna in Bengaluru; Editing by Chris Reese)

Brought to you by www.srnnews.com

Follow Us

WYSL LIVE

UPCOMING SHOWS

Recent Posts

Related Posts: